Cargando…

The immune responses to different Uropathogens call individual interventions for bladder infection

Urinary tract infection (UTI) caused by uropathogens is the most common infectious disease and significantly affects all aspects of the quality of life of the patients. However, uropathogens are increasingly becoming antibiotic-resistant, which threatens the only effective treatment option available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linlong, Li, Yangyang, Yang, Jiali, Xie, Xiang, Chen, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445553/ https://www.ncbi.nlm.nih.gov/pubmed/36081496 http://dx.doi.org/10.3389/fimmu.2022.953354

Ejemplares similares

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021)

Editorial: Immune intervention avenues to control fungal infections in immunocompromised individuals
por: Nanjappa, Som G.
Publicado: (2023)

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy
por: Ren, Chunyu, et al.
Publicado: (2023)

Transcriptional alterations in bladder epithelial cells in response to infection with different morphological states of uropathogenic Escherichia coli
por: Persson, Katarina, et al.
Publicado: (2022)

Uropathogenic Escherichia coli Infection Compromises the Blood-Testis Barrier by Disturbing mTORC1-mTORC2 Balance
por: Lu, Yongning, et al.
Publicado: (2021)

Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14
por: Tomasek, Kathrin, et al.
Publicado: (2022)

Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages
por: Mendez-Cortina, Yorjagis, et al.
Publicado: (2022)

Uropathogenic Escherichia coli Superinfection Enhances the Severity of Mouse Bladder Infection
por: Schwartz, Drew J., et al.
Publicado: (2015)

Immune status for monitoring and treatment of bladder cancer
por: Pan, Shen, et al.
Publicado: (2022)

Uropathogenic E. coli induces DNA damage in the bladder
por: Chagneau, Camille V., et al.
Publicado: (2021)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Activation of the NLRP3 Inflammasome Pathway by Prokineticin 2 in Testicular Macrophages of Uropathogenic Escherichia coli- Induced Orchitis
por: Li, Ying, et al.
Publicado: (2019)

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder
por: Feng, Huan, et al.
Publicado: (2023)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

Machine learning links different gene patterns of viral infection to immunosuppression and immune-related biomarkers in severe burns
por: Wang, Peng, et al.
Publicado: (2022)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Sex Differences in Immunity to Viral Infections
por: Jacobsen, Henning, et al.
Publicado: (2021)

The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer
por: Li, Jinze, et al.
Publicado: (2022)

Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
por: Song, Qiang, et al.
Publicado: (2022)

Data showing levels of interleukin-1β and nitric oxide in the plasma of uropathogenic E. coli infected UTI patients
por: Verma, Vivek, et al.
Publicado: (2018)

Corticosterone Enhances the AMPK-Mediated Immunosuppressive Phenotype of Testicular Macrophages During Uropathogenic Escherichia coli Induced Orchitis
por: Zhang, Zhengguo, et al.
Publicado: (2020)

Epithelial C5aR1 Signaling Enhances Uropathogenic Escherichia coli Adhesion to Human Renal Tubular Epithelial Cells
por: Song, Yun, et al.
Publicado: (2018)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

CRISPRi Induced Suppression of Fimbriae Gene (fimH) of a Uropathogenic Escherichia coli: An Approach to Inhibit Microbial Biofilms
por: Zuberi, Azna, et al.
Publicado: (2017)

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
por: Yi, Xianyanling, et al.
Publicado: (2022)

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019)

Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
por: Chang, Zhenglin, et al.
Publicado: (2022)

Hemagglutinin expressed by yeast reshapes immune microenvironment and gut microbiota to trigger diverse anti-infection response in infected birds
por: Xie, Ruyu, et al.
Publicado: (2023)

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
por: Bonilla, Hector, et al.
Publicado: (2023)

Uropathogenic E. coli Induce Different Immune Response in Testicular and Peritoneal Macrophages: Implications for Testicular Immune Privilege
por: Bhushan, Sudhanshu, et al.
Publicado: (2011)

UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies
por: Terlizzi, Maria E., et al.
Publicado: (2017)

Lactobacillus crispatus Limits Bladder Uropathogenic E. coli Infection by Triggering a Host Type I Interferon Response
por: Song, Chang Hyun, et al.
Publicado: (2022)

Group 3 Innate Lymphoid Cells Protect the Host from the Uropathogenic Escherichia coli Infection in the Bladder
por: Huang, Jiaoyan, et al.
Publicado: (2022)

Individuality in the Immune Repertoire and Induced Response of the Sponge Halichondria panicea
por: Schmittmann, Lara, et al.
Publicado: (2021)

Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection
por: Rhoades, Nicholas, et al.
Publicado: (2019)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021)

Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer
por: Xu, Ting, et al.
Publicado: (2022)

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer
por: Xu, Chao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92uclscdbamiqo48rbnu4i3sdj